Articles of the Month
Videos
Articles
Long-Term Effect of Allergen Immunotherapy in Responder Local Allergic Rhinitis Patients: Symptom Control, and Prevention of Asthma and Allergic Sensitizations
Testera-Montes, A., Zubiaga-Fernandez, L., Aranda, C.J., et al. Allergy. First published:19 November 2025
Effects of Butyrylated High Amylose Maize Starch (HAMSB) as an Adjuvant for Oral Immunotherapy
D. Ni, G. Pinget, B. Santner-Nanan, et al., Allergy. First published: 19 November 2025
Geographic Differences in Dupilumab Treatment Outcomes for Atopic Dermatitis: A Systematic Review and Meta-Regression Analysis
S. De Vriese, H. Belasri, F. M. S. Badloe, et al., Allergy. First published: 18 November 2025
A Systematic Review of Multidimensional Predictors for Refractory Chronic Rhinosinusitis: Clinical, Systemic and Local Insights
D. Wu, L. Shu, C. Wang, et al., Allergy. First published: 18 November 2025
Distinct Tryptase Gene Copy Number Variations Correlate With Tryptase Levels in a Population-Based Cohort
Y. Chantran, S. Choi, C. Roda, et al.,Allergy. First published: 17 November 2025
Gut Microbiome Alterations by Allergen Sensitisation and Symptom Severity in Paediatric Allergic Rhinitis
K. Miyake, D. Watanabe, S. Otawa, et al., Allergy. First published: 17 November 2025
Comparison of Two Methods to Analyse Exhaled Breath for Accurate Asthma Detection in School-Aged Children
M. van Aarle, S. Kienhorst, R. Vitale, et al., Allergy. First published: 14 November 2025
The Neurogenic Inflammation Mediator Endothelin-1 Causes Human Skin Barrier Disruption in Atopic Dermatitis via an ETAR/TRPA1-Axis
R. Leo, A. Jochebeth, N. Abdulrahman, et al., Allergy. First published: 14 November 2025
Long-Term Attenuation of Vascular Hyperpermeability in a Hereditary Angioedema Mouse Model by Adenine Base Editing
Y. Wang, Y. Kong, Y. Zhang, et al., Allergy. First published:14 November 2025
Molecular IgE Reactivity Profiling With Micro-Arrayed Allergens Reveals Distinct Interregional Patterns of Sensitization and a Hypoallergenic Region in Türkiye
A. Kazancioglu, H.-J. Huang, S. Aksakal, et al.,Allergy. First published: 13 November 2025
Allergological Work-Up in Cephalosporin Allergy Diagnosis and Delabelling: The Experience From Two European Allergy Centres
M. Salas, A. Ghilarducci, I. Doña, et al., Allergy. First published: 12 November 2025
Super-Responders” to Dupilumab Treatment in Patients With Primary Diffuse Chronic Rhinosinusitis With Nasal Polyps
P. E. Vonk, J. J. Otten, H. B. E. Elzinga, et al., Allergy. First published: 12 November 2025
A Straightforward Algorithm for Diagnosing Hymenoptera Venom Allergy and Identifying the Relevant Venom for Immunotherapy
L. Arzt-Gradwohl, E. Schadelbauer, U. Čerpes, et al., Allergy. First published: 12 November 2025
B-Cell Repertoire of Children With Atopic Dermatitis Exhibits Altered IgE Maturation Associated With Allergic Food Sensitization
K. K. Gill, C. Moore, O. Nwogu, et al., Allergy. First published: 11 November 2025
Cluster Analysis to Identify Distinct Asthma Phenotypes in the ATLANTIS Cohort
P. J. M. Kuks, T. Karp, J. E. Hartman, et al., Allergy. First published: 10 November 2025
Low-Dose Intralymphatic Immunotherapy for Grass Pollen Allergy is Both Safe and Effective
B. Hviid-Vyff, S. H. Skaarup, A. Duin, et al., Allergy. First published: 09 November 2025
Cryo-EM Structure of FcεRI Bound IgE Reveals Multiple Defined Conformations of the Fab-Fc Hinge
R. K. Jensen, M. Miehe, R. Gandini, et al., Allergy. First published: 08 November 2025
Decarbonising Respiratory Care: The Impact of a Low-Carbon Salbutamol Pressurised Metered-Dose Inhalers
J. King, A. Woodcock, A. Anzueto, et al., Allergy. First published: 06 November 2025
Novel Biomarkers and Diagnostic Tools in Food Allergy
S. Bunyavanich, M. Akdis, M. C. Berin, et al., Allergy. First published: 05 November 2025
Atopic Dermatitis (AD) Related Cord Blood DNA Methylation Patterns Are Linked to Maternal AD
L. Matzner, J. Denkena, M. Messingschlager, et al., Allergy. First published: 04 November 2025
Single-Cell Profiling Identifies TNF-Responsive Circulating Eosinophils in Allergic Rhinitis
S. Cai, Y. Zhao, S. Yao, P. et al., Allergy. First published: 04 November 2025
Improving Beta-Lactam Allergy Risk Stratification Through Digital Decision Support: A Randomized Crossover Study of BLAST-A
M. Y. Chong, W. Shi, M. Bulatović-Ćalasan, et al., Allergy. First published: 04 November 2025
Association Between Di-(2-Ethylhexyl) Phthalate and Childhood Asthma Through Plasma Metabolome Alterations
M. J. Kim, S. H. Lee, S. J. Kim, et al., Allergy. First published: 03 November 2025
Trajectory-Based Clustering to Identify Asthma Subgroups Responsive to the Selective CXCR2 Antagonist, AZD5069
K. Asamoah, F. Yang, I. M. Adcock, et al., Allergy. First published: 02 November 2025
Characteristics of Adolescents With Uncontrolled Severe Asthma Starting Dupilumab: The PEDIASTHMA Registry
S. Wanin, R. A. Taam, L. G. Chami, et al., Allergy. First published: 29 October 2025
Dynamic Regulation of Collagens, Proteases, Their Inhibitors, and Cell Death in Experimental Asthma in Mice
M. Tynecka, A. Tarasik, B. Hanczaruk, et al. Allergy. First published:28 October 2025
Bidirectional Associations Between Seborrheic Dermatitis and Epithelial Barrier Diseases: A Retrospective Cohort Study
S. Meng, R. Berna, J. Takeshita, et al. Allergy. First published: October 2025
The CXCL12-CXCR4 Axis Mediates Lymphocyte Immune Overactivation in IgG4-Related Chronic Rhinosinusitis
J. Ding, L. Cui, C. Wang, et al. Allergy. First published: 27 October 2025
Role of Inflammasome in IgE-Mediated Anaphylaxis
S. Fernandez-Bravo and R. Fernandez-Santamaria. Allergy. First published:25 October 2025
Increased Cardiovascular Risk in Chronic Spontaneous Urticaria: A Large Real-World Cohort Study
P. Curman, D. Thaçi, and R. J. Ludwig. Allergy. First published:25 October 2025
Cellular Stress, Inflammation and Barrier Damage in Gut Epithelial Cells Caused by Aspartame
Y. Pat, D. Yazici, C. Zeyneloglu, et al. Allergy. First published: 24 October 2025
Protective Role for Itaconate During Inhaled Allergen Challenge
G. J. Albers, P. P. Ogger, C. Michalaki et al. Allergy. First published: 24 October 2025
On the Kinetics of Human Skin Mast Cell Depletion and Repopulation Following KIT Inhibition
D. Alvarado, D. M. Maurer, P. Golden, et al. Allergy. First published: 24 October 2025
Wildfires and Atopic Diseases: A Review
A. Ha, J. R. Balmes, and M. L. Wei. Allergy. First published: 23 October 2025
Club Cells in Nasal Epithelial Repair: Insights From an IL-13-Induced Inflammatory Model
Z.-Q. Huang, J. Liu, J. Ye, et al. Allergy. First published: 22 October 2025
The Therapeutic Potential of Farm Dust Extracts in a Mouse Model of Eosinophilic Inflammation
R. Ü. Korkmaz, J. Omony, X. Tan, et al. Allergy. First published: 22 October 2025
Unifying Global Drug Allergy: Clarifying Concepts and Defining Low-Risk Penicillin Allergy
Li, P.H., Sabato, V., Khan, D.A., et al. Allergy. First published: 22 October 2025
Not All Rhinitis Follows the Atopic March: Early-Life Risk Factors and Implications of Infectious Disease Across Three Phenotypes in JECS Cohort
D. Harama, M. Saito-Abe, K. Pak, et al.,Allergy. First published: 21 October 2025
Human KIT Antibody Briquilimab Diminishes Anaphylactic Responses in Mice Expressing Chimeric Human-Mouse KIT
H.-S. Kwon, S. E. Lee, A. Sharma, et al. Allergy. First published: 21 October 2025
High Serum TSLP Is Characteristic of Late-Onset, Long-Duration, Eosinophilic Asthma
M. Suzukawa, K. Ohta, H. Tashimo, et al. Allergy. First published: 21 October 2025
An Anti-IL-13 Vaccine Reduces Atopic Dermatitis in Humanized Mice and Induces Neutralizing Antibodies in Nonhuman Primates
A. Mougel, K. Lemdani, N. Serhan, et al. Allergy. First published: 21 October 2025
Peanut Component-Specific IgE and IgG4 Are Modulated by Sublingual Immunotherapy and Are Associated With Remission in 1–4-Year-Old Children
N. Singh, J. Kesselring, J. Humphrey, et al. Allergy. First published: 21 October 2025
Safety of Drug Provocation Tests in Adults With and Without Clonal Mast Cell Disorders
F. Nalin, B. Olivieri, F. Olivieri, et al. Allergy. First published: 21 October 2025
Thaumatin-Like Proteins in Molecular Allergy Diagnostics: Uncommon Co-Sensitized, and Clinically Inconspicuous? Insights From an Italian Cohort
E. Scala, D. Abeni, M. Giani, et al. Allergy. First published: 21 October 2025
Prolonged IL-33 Exposure Switches the Secreted Mast Cell Cytokine Profile From Pro-Inflammatory to Pro-Tolerant
A. R. Teufelberger, C. Költgen, M. Babina, and P. Wolf. Allergy. First published:21 October 2025
Heavy Metals as Key Environmental Aggravators in Atopic Dermatitis in Companion Dogs: A One Health Perspective
J. Han, H.-W. Cha, Y. Eom, et al. Allergy. First published: 20 October 2025
Intrinsic Alterations of the Inflammatory Pathways in Primary Canine Atopic Keratinocytes
D. Santoro, L. Archer, G. Scotti, K. Ahrens, and A. Riva. Allergy. First published: 17 October 2025
Immune Training of the Interleukin 6 Gene in Airway Epithelial Cells is Central to Asthma Exacerbations
L. P. Lunding, M. Weckmann, U. M. Zissler et al. Allergy. First published: 16 October 2025
Ocular Microbiome in Dupilumab-Induced Ocular Surface Disease
A. Leonardi, R. Frizzo, F. Cavarzeran, et al. Allergy. First published: 16 October 2025
Asthma Remission in Adults: Role of Age at Asthma Onset, Smoking, Obesity, and Allergic Rhinitis
R. Abohalaka, S. Ercan, L. Lehtimäki, et al. Allergy. First published: 15 October 2025
Single Cell Analysis Reveals Dynamic Changes of Distinct Cell Populations in Human Nickel Allergy
M. Schmidt, A. Knorz, K. Mederet al. Allergy. First published: 15 October 2025
National Audit of Long-Term Real-World Outcomes of Berotralstat Use in UK Patients With Hereditary Angioedema
H. Elbashir, A. Dorr, M. Ahuja et al. Allergy. First published: 14 October 2025
Antibiotics for Acute Wheezing and Asthma Exacerbations: An EAACI Position Paper and Systematic Review
A.-L. Redel, W. Feleszko, M. Atanaskovic-Markovic, et al. Allergy. First published: 13 October 2025
Efficacy of Dupilumab in Asthma: Focus on Early, Progressive, and Long-Lasting Effects on Small Airways
M. Martini, L. Antonicelli, M. S. Garritani, et al. Allergy. First published:13 October 2025
Nasopharyngeal Microbiome-Epigenome-Wide Association Analysis in Infants With Severe Bronchiolitis
R. Shibata, Y. Li, A. Yaskolka Meir, et al. Allergy. First published: 13 October 2025
The Nasal Microbiome and Associations With Environmental Exposures and Respiratory Health
J. Perez-Garcia, A. K. Bozack, S. L. Rifas-Shiman, et al. Allergy. First published: 11 October 2025
Basophils in Skin-Mediated Sensitization Drive Subsequent Lung Inflammation in Airway-Challenged Mice
E. D. Choi, D. Voehringer, and D. Radtke. Allergy. First published: 11 October 2025
The Sting Challenge Test: An EAACI Position Paper on Hymenoptera Venom Allergy
A. V. Castro, C. Breynaert, T. Alfaya, et al. Allergy. First published: 11 October 2025
Genistein Reduced Eosinophilic Inflammation and Remodeling by Downregulating PAI-1 and TSLP
J. Y. Han, J.-Y. Lee, C.-G. Jung,et al. Allergy. First published: 11 October 2025
Forever Chemicals: An Exploratory, Population-Based Analysis of Per- and Polyfluoroalkyl Substances Exposure and Effects on Sinonasal Health
Chiang, S., Jung, Y.S., Thorley, W., et al. Allergy. First published:10 October 2025
SQ House Dust Mite Sublingual Immunotherapy Tablet in Children With Allergic Asthma: A Randomised Phase III Trial
G. Roberts, J. Just, H. Nolte, et al. Allergy. First published:09 October 2025
Genome-Wide Blood DNA Methylation Profiling in Birch Pollen Allergic Patients Undergoing Allergen-Specific Immunotherapy
A. Lahnsteiner, V. Ellmer, M. Hao, et al. Allergy. First published: 09 October 2025
Dupilumab in Children Under 6 Years With Moderate-to-Severe Atopic Dermatitis: A 16-Week Real-World Prospective Study on Efficacy, Safety, and Local-Systemic Immune Responses
Y. Zhang, J. Pi, L. Wang, et al.Allergy. First published: 07 Ocotober 2025
Asthma in Pregnancy
E. Denton, M. E. Jensen, B. K. Brew, et al. Allergy. First published:06 October 2025
Secretion of Peanut Protein With IgE Crosslinking Capacity in Human Milk
A. D. Burris, N. Diaz, J. B. Meddings, et al. Allergy. First published:01 October 2025
Long-Term, Real-World Effectiveness of Allergen Immunotherapy in Children and Adolescents With Allergic Rhinitis and Asthma
C. Woehlk, T. Stranzl, M. Contoli, et al. Allergy. First published: 01 October 2025
Citations: 342
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
Zuberbier, T, Abdul Latiff, AH, Abuzakouk, M, Aquilina, S, Asero, R, Baker, D, et al. Allergy. 2022; 77: 734– 766
Citations: 147
EAACI guidelines: Anaphylaxis (2021 update)
Muraro A, Worm M, Alviani C, et al. Allergy. 2022; 77: 357–377
Citations: 118
The international WAO/EAACI guideline for the management of hereditary angioedema—The 2021 revision and update
Maurer M, Magerl M, Betschel S, et al. Allergy. 2022; 77: 1961–1990
Citations: 118
The role of peripheral blood eosinophil counts in COVID-19 patients
Xie, G, Ding, F, Han, L, Yin, D, Lu, H, Zhang, M. Allergy. 2021; 76: 471– 482
Citations: 114
Epithelial barrier hypothesis: Effect of the external exposome on the microbiome and epithelial barriers in allergic disease
Celebi Sozener Z, Ozdel Ozturk B, Cerci P, et al. Allergy. 2022; 77: 1418–1449
Citations: 105
Basophil activation test: Mechanisms and considerations for use in clinical trials and clinical practice
Santos, A.F., Alpan, O. and Hoffmann, H.-J. Allergy. 2021; 76: 2420-2432
Citations: 92
Allergenic components of the mRNA-1273 vaccine for COVID-19: Possible involvement of polyethylene glycol and IgG-mediated complement activation
Klimek, L., Novak, N., Cabanillas, B., et al. Allergy. 2021; 76: 3307-3313
Citations: 90
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines
Sokolowska, M., Eiwegger, T., Ollert, M., Torres, M.J., Barber, D., Del Giacco, S., et al. Allergy. 2021; 76: 1629-1639
Citations: 88/h5>
The role of allergen-specific IgE, IgG and IgA in allergic disease
Shamji MH, Valenta R, Jardetzky T, et al. Allergy. 2021; 76: 3627–3641
Citations: 82
COVID-19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper
Pfaar, O, Klimek, L, Jutel, M, Akdis, C, A, Bousquet, J, Breiteneder, H, et al. Allergy. 2021; 76: 648– 676
Citations: 81
Advances and highlights in allergic rhinitis
Zhang Y, Lan F, Zhang L. Allergy. 2021; 76: 3383–3389
Citations: 79
Allergic reactions to the first COVID-19 vaccine: A potential role of polyethylene glycol?
Cabanillas, B., Akdis, C.A. and Novak, N. Allergy. 2021; 76: 1617-1618
Citations: 76
Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines
Agache, I., Song, Y., Alonso-Coello, P., Vogel, Y., Rocha, C., Solà, I., et al. Allergy. 2021; 76: 2337-2353
Citations: 74
Interleukin-31: The “itchy” cytokine in inflammation and therapy
Datsi, A., Steinhoff, M., Ahmad, F., Alam, M. and Buddenkotte, J. Allergy. 2021; 76: 2982-2997
Citations: 73
Endotypes of chronic rhinosinusitis: Relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches
Kato A, Peters AT, Stevens WW, Schleimer RP, Tan BK, Kern RC. Allergy. 2022; 77: 812–826
Citations: 70
Vaccines and allergic reactions: The past, the current COVID-19 pandemic, and future perspectives
Sampath, V., Rabinowitz, G., Shah, M., et al. Allergy. 2021; 76: 1640-1660
Citations: 69
Advances and highlights in biomarkers of allergic diseases
Ogulur I, Pat Y, Ardicli O, et al. Allergy. 2021; 76: 3659–3686
Citations: 69
Regulatory B cells, A to Z
Jansen, K., Cevhertas, L., Ma, S., Satitsuksanoa, P., Akdis, M. and van de Veen, W.
Citations: 62
Advances and highlights in asthma in 2021
Agache I, Eguiluz-Gracia I, Cojanu C, et al. Allergy. 2021; 76: 3390–3407
Citations: 62
Predictors of treatment response in chronic spontaneous urticaria
Fok, J.S., Kolkhir, P., Church, M.K. and Maurer, M. Allergy. 2021; 76: 2965-2981
Citations: 61
The ingenious mast cell: Contemporary insights into mast cell behavior and function
Dahlin, J.S., Maurer, M., Metcalfe, D.D., Pejler, G., Sagi-Eisenberg, R. and Nilsson, G. Allergy. 2022; 2022; 77: 83-99
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
Zuberbier, T, Abdul Latiff, AH, Abuzakouk, M, et al. Allergy. 2022; 77: 734– 766
The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
Zuberbier, T., Aberer, W., Asero, R., Abdul Latiff, A., H., Baker, D., Ballmer-Weber, B. et al. Allergy. 2018; 73: 1393- 1414
Risk factors for severe and critically ill COVID-19 patients: A review
Gao, Y-D, Ding, M, Dong, X, et al. Allergy. 2021; 76: 428– 455
Vaccines and allergic reactions: the past, the current COVID-19 pandemic, and future perspectives
Sampath, V., Rabinowitz, G., Shah, M., Jain, S., Diamant, Z., Jesenak, M. et al. Allergy. 2021; 76: 1640-1660
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581
EAACI guidelines: Anaphylaxis (2021 update)
Muraro, A, Worm, M, Alviani, C, et al. Allergy. 2022; 77: 357– 377
Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)
Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A. et al. Allergy. 2008; 63: 8-160
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741
Advances and recent developments in asthma in 2020
Cevhertas, L, Ogulur, I, Maurer, DJ, et al. Allergy. 2020; 75: 3124– 3146
The international WAO/EAACI guideline for the management of hereditary angioedema – the 2021 revision and update
Maurer, M., Magerl, M., Betschel, S., et al. Allergy. First published: 10 January 2022
A compendium answering 150 questions on COVID-19 and SARS-CoV-2
Riggioni, C., Comberiati, P., Giovannini, M., Agache, I., Akdis, M., Alves-Correia, M. et al. Allergy. 2020; 75: 2503– 2541
Special Issue: Perspectives in Allergen Immunotherapy: 2019 and Beyond
Volume 74 | Issue S108
Management of anaphylaxis due to COVID-19 vaccines in the elderly
Bousquet, J., Agache, I., Blain, H., et al. Allergy. 2021; 76: 2952-2964
Predictors of treatment response in chronic spontaneous urticaria
Fok, J.S., Kolkhir, P., Church, M.K. and Maurer, M. Allergy. 2021; 76: 2965-2981
Interleukin-31: The “itchy” cytokine in inflammation and therapy
Datsi, A., Steinhoff, M., Ahmad, F., Alam, M. and Buddenkotte, J. Allergy. 2021; 76: 2982-2997
Markers for the involvement of endothelial cells and the coagulation system in chronic urticaria: A systematic review
Mostmans, Y., De Smedt, K., Richert, B., et al. Allergy. 2021; 76: 2998-3016
Eczema herpeticum in atopic dermatitis
Traidl, S., Roesner, L., Zeitvogel, J. and Werfel, T. Allergy. 2021; 76: 3017-3027
CytoBas: Precision component-resolved diagnostics for allergy using flow cytometric staining of basophils with recombinant allergen tetramers
McKenzie, C.I., Varese, N., Aui, P.M., et al. Allergy. 2021; 76: 3028-3040
Heterogeneity of pollen food allergy syndrome in seven Southern European countries: The @IT.2020 multicenter study
Lipp, T, Acar Şahin, A, Aggelidis, X, et al. Allergy. 2021; 76: 3041– 3052
Direct assessment of individual skin barrier components by electrical impedance spectroscopy
Mannweiler, R., Bergmann, S., Vidal-y-Sy, S., Brandner, J.M. and Günzel, D. Allergy. 2021; 76: 3094-3106
Prenatal paraben exposure and atopic dermatitis-related outcomes among children
Thürmann, L, Herberth, G, Seiwert, B, et al. Allergy. 2021; 76: 3122– 3132
Free human DNA attenuates the activity of antimicrobial peptides in atopic dermatitis
Kopfnagel, V, Dreyer, S, Zeitvogel, J, et al. Allergy. 2021; 76: 3145– 3154
Nanoarchitectures for efficient IgE cross-linking on effector cells to study amoxicillin allergy
Tesfaye, A., Rodríguez-Nogales, A., Benedé, S., et al. Allergy. 2021; 76: 3183-3193
Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine
Darrigade, A.-S., Théophile, H., Sanchez-Pena, P., et al. Allergy. 2021; 76: 3194-3196
Transgenic mice overexpressing the PGE2 receptor EP2 on mast cells exhibit a protective phenotype in a model of allergic asthma
Urbano, A., Plaza, J., Turon, S., et al. Allergy. 2021; 76: 3196-3199
Type 2 biomarker expression (FeNO and blood eosinophils) is higher in severe adult-onset than in severe early-onset asthma
Lommatzsch, M., Klein, M., Stoll, P. and Virchow, J.C. Allergy. 2021; 76: 3199-3202
Identification of Ulocladium chartarum as an important indoor allergen source
Pfeiffer, S., Sandler, P., Raith, M., et al. Allergy. 2021; 76: 3202-3206
Effects of allergen immunotherapy in the MASK-air study: a proof-of-concept analysis
Pfaar, O., Sousa-Pinto, B., Devillier, P., et al. Allergy. 2021; 76: 3212-3214
Predicted number of peanut-allergic patients needed to treat with epicutaneous immunotherapy (EPIT) to prevent one allergic reaction: A novel approach to assessing relevance
Remington, B.C., Koppelman, S.J., Green, T.D., et al. Allergy. 2021; 76: 3223-3226
Legends of allergy and immunology: Sergio Bonini
Maltese, G. and Rasi, G. Allergy. 2021; 76: 3227-3229
Medical algorithm: Peri-operative management of mastocytosis patients
Bocca-Tjeertes, I.F.A., van de Ven, A.A.J.M., Koppelman, G.H., et al. Allergy. 2021; 76: 3233-3235
Open Access Agreements with Wiley
Check here if your research institution has an agreement with Wiley to make your Original Articles and Review Articles free to read, download and share by everyone: Institutional Payments | Wiley
Junior Members Corner
Dear Juniors,
We are delighted to share that the 9th edition of the EAACI Skin Allergy Club (SAC) was a complete success! Over two inspiring days (15–16 September 2025) in the always beautiful city of Paris, 15 participants were selected to give short presentations followed by group discussions. This small-group format fostered engaging conversations on the latest advances in the dermatological aspects of allergic reactions, in a relaxed and friendly atmosphere. It also encouraged collaboration and knowledge exchange among professionals and renowned experts in the field. This year, special emphasis was given to the traditional practical workshop, offering participants hands-on experience with common diagnostic tests used in the management of skin allergy disorders.
In addition, two of our EAACI Junior Member representatives attended the European Respiratory Society (ERS) Congress held in Amsterdam (27 September–1 October 2025). Organized by our sister society, this major event brought together more than 22,000 delegates interested in respiratory diseases to discuss the latest developments in the field. We would like to highlight the excellent sessions organized by our Early Career Member colleagues, including one focused on career development in respiratory medicine and the always entertaining “Science Slam.” Informal meetings between junior representatives from both societies also took place, further strengthening collaboration and exchange between our communities.
Best regards,
The Junior Member Assembly
EAACI Patients Organisation Committee Corner
HIGHLIGHTS FROM PAAM 2025
A group of ten Patient Organisations Committee (POC) members gathered at this wonderful venue in Palau de Congressos de Palma, Mallorca for 2025 Pediatric Allergy and Asthma Focused Meeting. Many had speaker slots giving lived experience perspectives of having children living with allergy and risk of anaphylaxis. So the EAACI PAAM Congress theme of ‘Inspiring insights for every family’ really resonated with us.
As POC, we are with EAACI to help where we can and it brings the science to a person experience, centred level. We had members a wide range of participants from Chile, USA, Turkey, UK, Sweden, Switzerland, France, Italy, Greece and Spain as POC has 36 POC members in 24 countries.
Our Chair, Ozlem Ceylan, gave an overview at the Opening Ceremony on why EAACI awareness campaigns matter, from awareness to action, so patients can feel heard and patient organisations can help lobby for policy change in their country.
POC participated in the Student Awareness Day that was set to educate 40 students aged 14-16 about allergic diseases and emergency response, with the local organising committee’s support.
One of our POC members, Esther Esteban Arroyo opened “The sister society session” with SEICAP and introduced their patient organisation, AEPNAA and their activities in Spain.
Mikaela Odemyr from Swedish Asthma and Allergy Association joined the Anaphylaxis session with a heartfelt talk, “When My Child Had Anaphylaxis: Expectations vs. Reality”. Fallon Schultz from IFPIES USA, gave a wonderful talk on parents’ perspective of dealing with a child’s FPIES journey and introduced their resources to support caregivers. On the last day of PAAM, Maria Zioga from Greece, gave a great talk, “From panic to preparedness: Building trust and resilience in food allergy care” and highlighted the importance of safety for food allergic children.
